Results 31 to 40 of about 26,442 (182)

Gabapentin for chronic refractory cancer cough

open access: yesIndian Journal of Palliative Care, 2016
Vagal sensory neuropathy or vagal hypersensitivity has been implicated in the pathophysiology of chronic cough. Earlier reports have shown gabapentin to be effective in sensory laryngeal neuropathy and symptom conditions that have a proven neural origin.
Atreya, Shrikant   +2 more
openaire   +2 more sources

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial

open access: yesRespiratory Research, 2023
Background P2X3 receptor antagonists seem to have a promising potential for treating patients with refractory chronic cough. In this double-blind, randomized, placebo-controlled study, we investigated the efficacy, safety, and tolerability of the novel ...
Christian Friedrich   +10 more
doaj   +1 more source

Chronic Refractory Cough [PDF]

open access: yesThe Korean Journal of Medicine, 2016
Chronic refractory cough is defined as a cough that persists despite guideline based treatment. It is seen in 20-46% of patients presenting to specialist cough clinics and it has a substantial impact on quality of life and healthcare utilization. Several terms have been used to describe this condition, including the recently introduced term cough ...
openaire   +1 more source

Validation of a visual analog scale for assessing cough severity in patients with chronic cough

open access: yesTherapeutic Advances in Respiratory Disease, 2021
Introduction: Patients with chronic cough experience considerable burden. The cough severity visual analog scale (VAS) records patients’ assessment of cough severity on a 100-mm linear scale ranging from “no cough” (0 mm) to “worst cough” (100 mm ...
Allison Martin Nguyen   +6 more
doaj   +1 more source

Where Eastern Medicine Meets Western Medicine: A World Review of the Management of Chronic Cough [PDF]

open access: yesWorld J Otorhinolaryngol Head Neck Surg
ABSTRACT Purpose To summarize current Western and Eastern approaches to the evaluation and management of chronic cough, with particular emphasis on etiology‐directed therapy, cough hypersensitivity, behavioral interventions, neuromodulators, procedural treatments, and traditional remedies.
Teng T   +5 more
europepmc   +2 more sources

Chronic cough and refractory chronic cough: An important distinction

open access: yesJournal of Precision Respiratory Medicine, 2023
Cough is the most common concern for which patients in the United States seek medical attention. Cough is typically classified according to its duration: acute cough (<3 weeks), subacute cough (3‐8 weeks), and chronic cough (>8 weeks). The vast majority of cases of acute cough in patients are due to an acute viral upper respiratory tract ...
openaire   +1 more source

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera   +4 more
wiley   +1 more source

Understanding the economic burden of chronic cough: a systematic literature review

open access: yesBMC Pulmonary Medicine, 2023
Chronic cough (CC) is associated with high healthcare resource utilization (HCRU) due to challenges in diagnosis and treatment and is anticipated to have a substantial economic impact.
Vishal Bali   +5 more
doaj   +1 more source

Treatment of recalcitrant cough with baclofen

open access: yesItalian Journal of Medicine, 2013
Background: Chronic dry cough is a debilitating symptom often refractory to standard antitussive therapy. It may result from increased sensitivity of the cough reflex. Baclofen, an agonist of gamma-aminobutyric acid (GABA), has been shown, in animals, to
Paolo Agostinis   +9 more
doaj   +1 more source

Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease

open access: yesMedicina
Background: Interstitial lung disease (ILD) is characterized by pulmonary inflammation and fibrosis associated with persistent and refractory cough that significantly hinders quality of life.
Tomoyuki Takahashi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy